Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-003985
Filing Date
2025-03-28
Accepted
2025-03-28 16:05:38
Documents
113
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K btai-20241231x10k.htm   iXBRL 10-K 3984598
2 EX-4.1 btai-20241231xex4d1.htm EX-4.1 16252
3 EX-4.5 btai-20241231xex4d5.htm EX-4.5 130099
4 EX-10.22_6 btai-20241231xex10d226.htm EX-10.22_6 411767
5 EX-19.1 btai-20241231xex19d1.htm EX-19.1 131199
6 EX-21.1 btai-20241231xex21d1.htm EX-21.1 1313
7 EX-23.1 btai-20241231xex23d1.htm EX-23.1 4478
8 EX-31.1 btai-20241231xex31d1.htm EX-31.1 25927
9 EX-31.2 btai-20241231xex31d2.htm EX-31.2 31624
10 EX-32.1 btai-20241231xex32d1.htm EX-32.1 11133
11 EX-32.2 btai-20241231xex32d2.htm EX-32.2 10193
12 GRAPHIC btai-20241231x10k001.jpg GRAPHIC 82572
13 GRAPHIC btai-20241231x10k002.jpg GRAPHIC 92027
14 GRAPHIC btai-20241231x10k003.jpg GRAPHIC 74182
15 GRAPHIC btai-20241231x10k004.jpg GRAPHIC 75124
16 GRAPHIC btai-20241231x10k005.jpg GRAPHIC 99598
17 GRAPHIC btai-20241231x10k006.jpg GRAPHIC 81326
18 GRAPHIC btai-20241231x10k007.jpg GRAPHIC 111418
19 GRAPHIC btai-20241231x10k008.jpg GRAPHIC 93892
20 GRAPHIC btai-20241231xex4d5001.jpg GRAPHIC 2371
  Complete submission text file 0001558370-25-003985.txt   15588879

Data Files

Seq Description Document Type Size
21 EX-101.SCH btai-20241231.xsd EX-101.SCH 69850
22 EX-101.CAL btai-20241231_cal.xml EX-101.CAL 76173
23 EX-101.DEF btai-20241231_def.xml EX-101.DEF 322032
24 EX-101.LAB btai-20241231_lab.xml EX-101.LAB 677711
25 EX-101.PRE btai-20241231_pre.xml EX-101.PRE 516213
117 EXTRACTED XBRL INSTANCE DOCUMENT btai-20241231x10k_htm.xml XML 1989209
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38410 | Film No.: 25785937
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)